Related Experiment Videos
Prestroke antihypertensive therapy: effect on the outcome
Katarzyna Grabska1, Grażyna Gromadzka, Anna Członkowska
12nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland. kgrabska@ipin.edu.pl
Summary
Pre-stroke hypertension treatment improves outcomes for ischemic stroke patients. Managing high blood pressure before a stroke is crucial for better recovery and reduced dependency.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Public Health
Background:
- Hypertension is a prevalent comorbidity in stroke patients, affecting approximately 70%.
- Elevated blood pressure during the acute phase of stroke is associated with poorer patient outcomes.
- Pre-stroke hypertension management strategies require further investigation regarding their impact on stroke prognosis.
Purpose of the Study:
- To investigate the association between pre-stroke antihypertensive treatment and 30-day outcomes in patients with ischemic stroke.
- To determine if prior use of blood pressure-lowering medications influences stroke severity and recovery.
Main Methods:
- Analysis of 1306 patients diagnosed with ischemic stroke.
- Classification of patients based on history of hypertension and pre-stroke antihypertensive treatment.
- Multivariate logistic regression modeling to identify predictors of 30-day outcomes (death or dependency).
Main Results:
- A significant proportion of ischemic stroke patients (81.8%) were on antihypertensive treatment prior to stroke.
- Pre-stroke use of antihypertensives was an independent predictor of better 30-day outcomes.
- Patients treated before stroke onset showed reduced rates of death or dependency.
Conclusions:
- Antihypertensive treatment before stroke onset is associated with improved functional outcomes.
- Optimizing hypertension diagnosis and control is essential for mitigating stroke-related morbidity and mortality.
- Further research into pre-stroke hypertension management could enhance stroke care protocols.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...